Analysis of EEG dynamics in epileptic children during carbamazepine therapy

1. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47:1094-120.10.1111/j.1528-1167.2006.00585.xSearch in Google Scholar

2. Goodridge PMG, Shorvon SD. Epileptic seizures in a population of 6000. 2 Treatment and prognosis. Brit Med. 1983; l:645-7.10.1136/bmj.287.6393.645Search in Google Scholar

3. Hart YM, Sander J WAS, Johnson AL, Shorvon SD. National general practice study of epilepsy: recurrence after a first seizure. Lancet. 1990; 1:1271-4.10.1016/0140-6736(90)92960-PSearch in Google Scholar

4. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39(1):5-17.10.1111/j.1528-1157.1998.tb01268.xOpen DOISearch in Google Scholar

5. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487-9.10.1212/WNL.33.11.1487Open DOISearch in Google Scholar

6. Genton P, Gelisse R, Thomas P., Dravet C. Do Caramazepine and Pheniton aggravate juvenile myclonic epilepsy? Neurology. 2000; 55:1106-9.10.1212/WNL.55.8.1106Open DOISearch in Google Scholar

7. Stefan H, Wang Y, Pauli E, Schmidt B. A new approach in anti-epileptic drug evaluation. Eur J Neurol. 2004; 11: 467-73.10.1111/j.1468-1331.2004.00812.xOpen DOISearch in Google Scholar

8. Corda D, Gelisse P, Dravet C, Baldy-Mouiner M. Incidence of drug-induced aggravation in Benign epilepsy with centotemporal spikes. Epilepsia. 2001; 42: 754-59.10.1046/j.1528-1157.2001.30000.xSearch in Google Scholar

9. Horn C, Ater S, Hurst D. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol. 1986; 2:340-5.10.1016/0887-8994(86)90074-3Open DOISearch in Google Scholar

10. Beaumanoir A. The Landay-Kleffner syndroe. In: Roger J, Bureau M, Dravet C, Genton CP, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 231-43.Search in Google Scholar

11. Tassinari C, Bureau M, Dravet C. Epilepsy with continuous spikes and waves during slow sleep: otherwise with described with electrical status epilepticus during slow sleep (ESES) In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 254-56.Search in Google Scholar

12. Rho J M, Shankar R. The pharmacological basis of antiepileptic drugs action. Epilepsia. 1999; 40:1471-83.10.1111/j.1528-1157.1999.tb02029.x10565572Search in Google Scholar

13. Macdonald RL, Meldrum BS. Principles of antiepileptic drug action. In: Levy R, Mattson R, Meldrum B. Penry JK, Dreifuss FE, editors. Antiepileptic drugs. NewYork;Raven Press, 1989. p. 59-83.Search in Google Scholar

14. Granger P, Biton B, Faure C., Vige X, Depoortere H, Graham D, Langer SZ, Scatton B, Avenet P. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol. 1995; 47:1189-96.Search in Google Scholar

15. Sramek J, Zarotsky V, Cutler N. Generalised anxiety disorder: treatment options. Drugs. 2002; 62:1635-48. 10.2165/00003495-200262110-00005Search in Google Scholar

16. Clemens B, Piros P, Bessenyei M, Hollody K. Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy. Clin Neurophysiol. 2007; 118: 910-7.10.1016/j.clinph.2006.11.016Open DOISearch in Google Scholar

17. Clemens B, Menes A, Piros P, Bessenyei M, Altmann A, Jerney J, et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res. 2006; 70:190-9.10.1016/j.eplepsyres.2006.05.003Open DOISearch in Google Scholar

18. Salinsky MC, Oken BS, Storzbach D, Dodrill CB. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia. 2003; 44: 1042-50.10.1046/j.1528-1157.2003.60602.xSearch in Google Scholar

19. Neufeld MY, Kogan E, Chistik V, Korczyn AD. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Clin Neuropharmacol. 1999; 22:80-6.10.1097/00002826-199903000-00003Search in Google Scholar

20. Drake ME, Padamadan H, Newell SA. Interictal quantitative EEG in epilepsy. Seizure. 1998; 7:39-42.10.1016/S1059-1311(98)90006-1Search in Google Scholar

21. Salinsky MC, Oken BS, Morehead L. Intraindividual analysis of antiepileptic drug effects on EEG background rhythms. Electroencephalogr Clin Neurophysiol. 1994 ; 90:186-93.10.1016/0013-4694(94)90090-6Open DOISearch in Google Scholar

22. Herkes GK, Lagerlund TD, Sharbrough FW, Eadie MJ. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol. 1993; 10:210-6.10.1097/00004691-199304000-00008Search in Google Scholar

23. Besser R, Hornung K, Theisohn M, Rothacher G, Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol. 1992; 83:19-23.10.1016/0013-4694(92)90128-5Open DOISearch in Google Scholar

24. Kalviainen R, Aikia M, Partanen J, Sivenius J, Mumford J, Saksa M, et al. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J Child Neurol. 1991; Suppl 2: 60-9.10.1177/0883073891006002111Search in Google Scholar

25. Miyauchi T, Endo K, Yamaguchi T, Hagimoto H. Computerized analysis of EEG background activity in epileptic patients. Epilepsia. 1991; 32:870-81.10.1111/j.1528-1157.1991.tb05544.xOpen DOISearch in Google Scholar

26. Fonseca LC, Tedrus GM, Chiodi MG, Cerqueira JN, Duran MH. Quantitative electroencephalography in children with benign childhood epilepsy with centrotemporal spikes: analysis of band power. Arq Neuropsiquiatr. 2004; 62:455-8.10.1590/S0004-282X2004000300014Search in Google Scholar

27. Camfield P, Gordon K, Camfield C, Tibbles J, Dooley J, Smith B. EEG results are rarely the same if repeated within six months in childhood epilepsy. Can J Neurol Sci. 1995; 22:297-300.10.1017/S0317167100039512Open DOISearch in Google Scholar

28. Konishi T, Naganuma Y, Hongou K, Murakami M, Yamatani M, Okada T. Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy. Clin Electroencephalogr. 1995; 26:113-9.10.1177/155005949502600209Search in Google Scholar

29. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of the epilipsies and epileptic syndromes. Epilepsia, 1989; 30:389-99.10.1111/j.1528-1157.1989.tb05316.xSearch in Google Scholar

30. American EEG Society Guidelines in EEG, 1-7, 13 (Revised 1994). J Clin Neurophysiol. 1994; 11: 1-143. Search in Google Scholar

31. Harmony T, Hinojosa G, Marosi E, Becker J, Rodriguez M, Reyes A, et al. Correlation between EEG spectral parameters and educational evaluation. Inter J Neurosci. 1990; 54:147-55.10.3109/00207459008986630Search in Google Scholar

32. Benninger C, Matthis P, Scheffner D. EEG development of healthy boys and girls. Results of a longitudinal study. Electroencephalogr Clin Neurophysiol. 1984; 57:1-12.10.1016/0013-4694(84)90002-6Search in Google Scholar

33. Niedermeyer E. Maturation of the EEG: development of waking and sleep patterns. In: Electroencephalography. Basic Principles, Clinical Applications and Related Fields. Niedermeyer E, Lopes Da Silva F, editors. Urban & Schvarzenberg, 1983, p. 107-30.Search in Google Scholar

34. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin. 1945; 1: 80-3.10.2307/3001968Search in Google Scholar

35. Genton P, McMenamin J. Aggravation of seizure by antiepileptic drugs: what to do in clinical practice. Epilepsia. 1998; 39:26-9.10.1111/j.1528-1157.1998.tb05119.x9593233Open DOISearch in Google Scholar

36. Frost JD Jr, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. Clin Neurophysiol. 1995; 1:57-63.Search in Google Scholar

37. Wu X, Xiao CH. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clin Electroencephalogr. 1996; 27:40-5.10.1177/1550059496027001078719501Search in Google Scholar

38. Khachidze I, Maloletnev V, Mamukashvili M. Effect of the sodium valproate on EEG pattern in epileptic patients. Proc Georgian Acad Sci. 2006; 5:1109-14.Search in Google Scholar

39. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002; 5:482-90.10.1046/j.1528-1157.2002.22501.x12027908Search in Google Scholar

40. Garcia-Borreguero D, Bronisch T, Apelt S, Yassouridis A, Emrich H M. Treatment of benzodiazepine withdrawal symptoms with carbamazepine. Eur Arch Psychiatry Clin Neurosci. 1991; 3:145-50.10.1007/BF022197131686406Open DOISearch in Google Scholar

41. Stefan H, Fraunberger B. Valproate sustained release in the treatment of epilepsy. Fortschr Neurol Psychiatr. 2005; 73:681-6.10.1055/s-2004-83029916283612Search in Google Scholar

42. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006; 2:790-8.10.1124/jpet.106.10496816895979Search in Google Scholar

43. Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005; 63:141-9.10.1016/j.eplepsyres.2005.02.00215777732Open DOISearch in Google Scholar

44. Goyal V, Bhatia M, Behari M. Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability. J Transcranial Magnetic Evaluation. 2004; 2: 224-7.Search in Google Scholar

45. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurology. 2002; 9:41-7.10.1046/j.1468-1331.2002.00317.x11784375Search in Google Scholar

46. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia. 1994; 35:1154-9.10.1111/j.1528-1157.1994.tb01782.x7988504Open DOISearch in Google Scholar

47. Guerrini R, Belmonte A, Genton P. Antiepileptic druginduced worsening of seizures in children. Epilepsia. 1998; 39(Suppl 3):2-10.10.1111/j.1528-1157.1998.tb05118.x9593229Search in Google Scholar

48. Stefan H, Lopes da Silva FH, Löscher W, Schmidt D, Perucca E, Brodie MJ. et al. Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand. 2006; 113:139-55.10.1111/j.1600-0404.2005.00561.x16441243Search in Google Scholar